|
2008 Journal Article Transmembrane protein 50b (C21orf4), a candidate for Down syndrome neurophenotypes, encodes an intracellular membrane protein expressed in the rodent brainMoldrich, R. X., Laine, J., Visel, A., Beart, P. M., Laffaire, J., Rossier, J. and Potier, M. C. (2008). Transmembrane protein 50b (C21orf4), a candidate for Down syndrome neurophenotypes, encodes an intracellular membrane protein expressed in the rodent brain. Neuroscience, 154 (4), 1255-1266. doi: 10.1016/j.neuroscience.2008.01.089 |
|
2008 Journal Article Nuclear Factor I Gene Expression in the Developing ForebrainPlachez, Celine, Lindwall, Charlotta, Sunn, Nana, Piper, Michael, Moldrich, Randal X., Campbell, Christine E., Osinski, Jason M., Gronostajski, Richard M. and Richards, Linda J. (2008). Nuclear Factor I Gene Expression in the Developing Forebrain. Journal of Comparative Neurology, 508 (3), 385-401. doi: 10.1002/cne.21645 |
|
2007 Journal Article A yeast model of Down syndromeMoldrich, R. X. (2007). A yeast model of Down syndrome. International journal of developmental neuroscience, 25 (8), 539-543. doi: 10.1016/j.ijdevneu.2007.10.001 |
|
2007 Journal Article Down syndrome gene dosage imbalance on cerebellum developmentMoldrich, Randal X., Dauphinot, Luce, Laffaire, Julien, Rossier, Jean and Potier, Marie-Claude (2007). Down syndrome gene dosage imbalance on cerebellum development. Progress in Neurobiology, 82 (2), 87-94. doi: 10.1016/j.pneurobio.2007.02.006 |
|
2006 Journal Article Transcriptional disruptions in Down syndrome: A case study in the Ts1Cje mouse cerebellum during post-natal developmentPotier, M.-C., Rivals, I., Mercier, G., Ettwiller, L., Moldrich, R. X., Laffaire, J., Personnaz, L., Rossier, J. and Dauphinot, L. (2006). Transcriptional disruptions in Down syndrome: A case study in the Ts1Cje mouse cerebellum during post-natal development. Journal of Neurochemistry, 97 (s1), 104-109. doi: 10.1111/j.1471-4159.2005.03624.x |
|
2005 Journal Article The cerebellar transcriptome during postnatal development of the Ts1Cje mouse, a segmental trisomy model for Down syndromeDauphinot, L., Lyle, R., Rivals, I., Dang, M.T., Moldrich, R. X., Golfier, G., Ettwiller, L., Toyama, K., Rossier, J., Personnaz, L., Antonarakis, S. E., Epstein, C. J., Sinet, P. M. and Potier, M. C. (2005). The cerebellar transcriptome during postnatal development of the Ts1Cje mouse, a segmental trisomy model for Down syndrome. Human Molecular Genetics, 14 (3), 373-384. doi: 10.1093/hmg/ddi033 |
|
2005 Journal Article Vampire bat salivary plasminogen activator (desmoteplase) inhibits tissue-type plasminogen activator-induced potentiation of excitotoxic injuryReddrop, C, Moldrich, RX, Beart, PM, Farso, M, Liberatore, GT, Howells, DW, Petersen, KU, Schleuning, WD and Medcalf, RL (2005). Vampire bat salivary plasminogen activator (desmoteplase) inhibits tissue-type plasminogen activator-induced potentiation of excitotoxic injury. Stroke, 36 (6), 1241-1246. doi: 10.1161/01.STR.0000166050.84056.48 |
|
2004 Conference Publication Transcriptome modifications in postnatal cerebellum devleopment of Ts1Cje mice, a model for Trisomy 21Potier, MC, Dauphinot, L, Dang, MT, Golfier, G, Moldrich, R, Rossier, J, Toyama, K, Sinet, PM, Rivals, I, Personnaz, L, Lyle, R, Antonarakis, S and Epstein, C (2004). Transcriptome modifications in postnatal cerebellum devleopment of Ts1Cje mice, a model for Trisomy 21. 35th Annual Meeting of the Transactions-of-the-American-Society-for-Neurochemistry, New York Ny, Aug 14-18, 2004. OXFORD: BLACKWELL PUBLISHING LTD. |
|
2003 Journal Article Glutamate metabotropic receptors as targets for drug therapy in epilepsyMoldrich, RX, Chapman, AG, De Sarro, G and Meldrumb, BS (2003). Glutamate metabotropic receptors as targets for drug therapy in epilepsy. European Journal of Pharmacology, 476 (1-2), 3-16. doi: 10.1016/S0014-2999(03)02149-6 |
|
2003 Journal Article Emerging Signalling and Protein Interactions Mediated Via Metabotropic Glutamate ReceptorsMoldrich, R. X. and Beart, P. M. (2003). Emerging Signalling and Protein Interactions Mediated Via Metabotropic Glutamate Receptors. Current Drug Targets, 2 (2), 109-122. doi: 10.2174/1568007033482922 |
|
2003 Journal Article Modulation of intracellular Ca2+ levels by Scorpaenidae venomsChurch, JE, Moldrich, RX, Beart, PM and Hodgson, WC (2003). Modulation of intracellular Ca2+ levels by Scorpaenidae venoms. Toxicon, 41 (6), 679-689. doi: 10.1016/S0041-0101(03)00038-2 |
|
2002 Conference Publication The mGlu2/3 agonist 2R,4R-APDC induces adenosine release via phospholipase C and calmodulin kinase in cultured murine astrocytes.Moldrich, RX, Aprico, K, O'Shea, RD and Beart, PM (2002). The mGlu2/3 agonist 2R,4R-APDC induces adenosine release via phospholipase C and calmodulin kinase in cultured murine astrocytes.. 4th International Meeting on Metabotropic Glutamate Receptors, Taorimina Italy, Sep 15-20, 2002. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD. |
|
2002 Conference Publication Astrocyte mGlu(2/3)-mediated camp potentiation is calcium sensitive: Studies in murine neuronal and astrocyte culturesBeart, PM, Aprico, K, O'Shea, RD and Moldrich, RX (2002). Astrocyte mGlu(2/3)-mediated camp potentiation is calcium sensitive: Studies in murine neuronal and astrocyte cultures. 4th International Meeting on Metabotropic Glutamate Receptors, Taorimina Italy, Sep 15-20, 2002. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD. |
|
2002 Journal Article Astrocyte mGlu(2/3)-mediated cAMP potentiation is calcium sensitive: studies in murine neuronal and astrocyte culturesMoldrich, RX, Aprico, K, Diwakarla, S, O'Shea, RD and Beart, PM (2002). Astrocyte mGlu(2/3)-mediated cAMP potentiation is calcium sensitive: studies in murine neuronal and astrocyte cultures. Neuropharmacology, 43 (2), 189-203. doi: 10.1016/S0028-3908(02)00111-9 |
|
2001 Conference Publication The mGlu2/3 agonist 2R,4R-4-aminopyrrolidine-2,4-dicarboxylate (2R,4R-APDC) and injury in murine pure neuronal culturesMoldrich, RX and Beart, PM (2001). The mGlu2/3 agonist 2R,4R-4-aminopyrrolidine-2,4-dicarboxylate (2R,4R-APDC) and injury in murine pure neuronal cultures. OXFORD: BLACKWELL SCIENCE LTD. |
|
2001 Journal Article Anti-epileptic activity of group II metabotropic glutamate receptor agonists (-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268) and (-)-2-thia-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY389795)Moldrich, RX, Jeffrey, M, Talebi, A, Beart, PM, Chapman, AG and Meldrum, BS (2001). Anti-epileptic activity of group II metabotropic glutamate receptor agonists (-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268) and (-)-2-thia-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY389795). Neuropharmacology, 41 (1), 8-18. doi: 10.1016/S0028-3908(01)00044-2 |
|
2001 Conference Publication Kainate receptors, cellular signaling and excitotoxic neuronal death: New pharmacological evidence for the functional involvement of low-affinity and metabotropic kainate receptorsGiardina, SF, Carroll, FY, Moldrich, RX, Finkelstein, DI, Horne, MK, Lawrence, AJ, Cheung, NS and Beart, PM (2001). Kainate receptors, cellular signaling and excitotoxic neuronal death: New pharmacological evidence for the functional involvement of low-affinity and metabotropic kainate receptors. Meeting on Excitatory Amino Acids - 10 Years Later, Manaus Brazil, Nov 18-22, 1998. AMSTERDAM: I O S PRESS. |
|
2001 Journal Article The mGlu(2/3) agonist 2R,4R-4-aminopyrrolidine-2,4-dicarboxylate, is anti- and proconvulsant in DBA/2 miceMoldrich, RX, Talebi, A, Beart, PM, Chapman, AG and Meldrum, BS (2001). The mGlu(2/3) agonist 2R,4R-4-aminopyrrolidine-2,4-dicarboxylate, is anti- and proconvulsant in DBA/2 mice. Neuroscience Letters, 299 (1-2), 125-129. doi: 10.1016/S0304-3940(00)01732-8 |
|
2001 Journal Article Group II mGlu receptor agonists fail to protect against various neurotoxic insults induced in murine cortical, striatal and cerebellar granular pure neuronal culturesMoldrich, RX, Giardina, SF and Beart, PM (2001). Group II mGlu receptor agonists fail to protect against various neurotoxic insults induced in murine cortical, striatal and cerebellar granular pure neuronal cultures. Neuropharmacology, 41 (1), 19-31. doi: 10.1016/S0028-3908(01)00045-4 |
|
2001 Journal Article Anticonvulsant activity of 3,4-dicarboxyphenylglycines in DBA/2 miceMoldrich, RX, Beart, PM, Jane, DE, Chapman, AG and Meldrum, BS (2001). Anticonvulsant activity of 3,4-dicarboxyphenylglycines in DBA/2 mice. Neuropharmacology, 40 (5), 732-735. doi: 10.1016/S0028-3908(01)00002-8 |
